Home / Fidelity / FIDELITY ADVISOR SERIES VII / Fidelity Advisor Biotechnology Fund
Fidelity Advisor Biotechnology Fund
A series of FIDELITY ADVISOR SERIES VII
- Vote records
- 500year to 30 June 2026
- Against management
- 8.0%40 of 500 marked votes
- Say-on-pay support
- 89.8%for, of for + against + abstain
- Shareholder-proposal support
- 0.0%for, of for + against + abstain
Fidelity Advisor Biotechnology Fund is a series of FIDELITY ADVISOR SERIES VII. For the year to 30 June 2026 its registrant reported 500 vote records for the series; 8.0% of the votes marked for or against management went against management. It voted for 89.8% of say-on-pay items and for 0.0% of proposals from security holders.
Compared with its registrant and family
| year to 30 June 2026 | This series | Its registrant | Fidelity | Median fund registrant |
|---|---|---|---|---|
| Against-management share | 8.0% | 4.9% | 6.0% | 6.2% |
| Say-on-pay support rate | 89.8% | 95.8% | 94.7% | 91.6% |
| Shareholder-proposal support rate | 0.0% | 19.5% | 27.6% | 27.5% |
Votes by category
foragainstabstain, withhold or otheramber tick: the portion cast against management
| Category (as the form names it) | Votes | For | Against | Against management | Split |
|---|---|---|---|---|---|
| DIRECTOR ELECTIONS | 257 | 246 | 1 | 4.3% | |
| SECTION 14A SAY-ON-PAY VOTES | 73 | 53 | 6 | 8.2% | |
| AUDIT-RELATED | 74 | 74 | 0 | 0.0% | |
| SHAREHOLDER RIGHTS AND DEFENSES | 2 | 2 | 0 | 0.0% | |
| CAPITAL STRUCTURE | 38 | 27 | 11 | 28.9% | |
| COMPENSATION | 30 | 20 | 10 | 36.7% | |
| CORPORATE GOVERNANCE | 29 | 25 | 4 | 3.4% | |
| ENVIRONMENT OR CLIMATE | 1 | 0 | 1 | 0.0% | |
| DIVERSITY, EQUITY, AND INCLUSION | 1 | 0 | 1 | 0.0% | |
| OTHER SOCIAL ISSUES | 2 | 0 | 2 | 0.0% |
By season
| Season | Vote records | Against management | Say-on-pay support | Shareholder-proposal support |
|---|---|---|---|---|
| year to 30 June 2026 | 500 | 8.0% | 89.8% | 0.0% |
Questions
How often did Fidelity Advisor Biotechnology Fund vote against management?
8.0% of the votes its registrant marked for or against management in the year to 30 June 2026 (40 of 500).
How did Fidelity Advisor Biotechnology Fund vote on executive pay?
It voted for 53 of 59 say-on-pay items cast for, against or abstain (89.8%).
Is this the result of the meetings?
No. Form N-PX shows how the fund voted the shares it held. It does not show how other shareholders voted or what the outcome was.
Where does the data come from?
From the Form N-PX filed by FIDELITY ADVISOR SERIES VII, which lists the series that cast each vote. The SEC does not verify the contents. Data runs through 23 Sep 2026.
Provenance: SEC EDGAR, Form N-PX filed by FIDELITY ADVISOR SERIES VII (filer no. 315700); votes attributed to series S000005321 by the filer. Not verified by the SEC. Filings read through 23 Sep 2026.